Fetal monitoring for high-risk pregnancies using a wearable ultrasound patch

Nature Biotechnology - Issue - nature.com science feeds

By: Geonho Park · Yizhou Bian · Hao Huang · Sai Zhou · Siyu Qin · Muyang Lin · Xinyi Yang · Aaron Lee · Anand Ramkumar · Mariana Tome · Jayne Lander · Xiangjun Chen · Shenghan Wang · Pranavi Bheemreddy · Liam Stanton · Ren Sheng · Guihuan Guo · Mabel Shehada · Ruotao Wang · Alexa Roa · Chengchangfeng Lu · Wentong Yue · Ray S. Wu · Xiaoxiang Gao · Hongjie Hu · Amer Yaghi · Mark Liu · Lawrence Impey · Sally L. Collins · Aris T. Papageorghiou · Louise C. Laurent · Keith A. Wear · Antoniya Georgieva · Sheng Xu

26 May 2026 at 08:00

Nature Biotechnology, Published online: 26 May 2026; doi:10.1038/s41587-026-03140-1

A wearable ultrasound device is optimized for continuous monitoring of pregnancies.

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study

Nature Cancer

By: Anuradha Jayaram · Memuna Rashid · Alison H. M. Reid · Francesco Orlando · Suparna Thakali · Leila Zakka · Miriam Goncalves · Jacqueline O’Dwyer · Constantine Alifrangis · Rob Jones · Elias Pintus · Sarah Needleman · Diletta Bianchini · Anna Wingate · Kenrick Ng · Mark Linch · Ursula McGovern · John Staffurth · Simon J. Crabb · Susannah Brock · Alison Birtle · Osvaldas Vainauskas · Gianmarco Leone · Millenn Chiwewe · Allan Hackshaw · Andre Lopes · Daniel Wetterskog · Francesca Demichelis · Gerhardt Attard

15 May 2026 at 08:00

Nature Cancer, Published online: 15 May 2026; doi:10.1038/s43018-026-01172-9

Jayaram et al. assessed the performance of the combination of circulating tumor DNA and serum prostate-specific antigen for dynamic monitoring of metastatic prostate cancer at first-line treatment in this prospective observational clinical trial.

Mitochondrial control of glycerolipid synthesis by a PEP shuttle

Cell

By: Tadashi Yamamuro · Daisuke Katoh · Guilherme Martins Silva · Hiroshi Nishida · Satoshi Oikawa · Yusuke Higuchi · Dandan Wang · Masanori Fujimoto · Naofumi Yoshida · Mark Li · Jihoon Shin · Zezhou Zhao · Jin-Seon Yook · Lijun Sun · Shingo Kajimura

17 March 2026 at 08:00

SLC25A35 is revealed as the mitochondrial PEP exporter that licenses glycerolipid synthesis in lipogenic cells, linking mitochondrial energetics to lipid production. Mitochondrial PEP flux drives glycerol-3-phosphate and triglyceride synthesis, and blocking SLC25A35 reduces hepatic steatosis, offering a target for metabolic therapy.

Reading view